View Financial HealthCell Point (India) 배당 및 자사주 매입배당 기준 점검 0/6Cell Point (India) 현재 배당금을 지급하지 않습니다.핵심 정보0%배당 수익률0%자사주 매입 수익률총 주주 수익률0%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향0%최근 배당 및 자사주 매입 업데이트공시 • Sep 27Cell Point (India) Limited Declares Final Dividend for the Financial Year Ended March 31, 2024Cell Point (India) Limited announced at the AGM held on September 27, 2024, approved declare final dividend on equity shares at the rate of 2.5% [i.e. INR 0.25/- (Rupees Twenty Five paisa only) per Equity Share of Face Value of INR 10/- (Rupees Twenty Five paisa only) for the financial year ended March 31, 2024.모든 업데이트 보기Recent updates공시 • 23hCell Point (India) Limited to Report Second Half, 2026 Results on May 27, 2026Cell Point (India) Limited announced that they will report second half, 2026 results on May 27, 2026Valuation Update With 7 Day Price Move • Apr 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹15.60, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Specialty Retail industry in India. Total loss to shareholders of 13% over the past year.New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. Market cap is less than US$10m (₹254.1m market cap, or US$2.72m). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Large one-off items impacting financial results.Reported Earnings • Nov 18First half 2026 earnings released: EPS: ₹0.10 (vs ₹0.12 in 1H 2025)First half 2026 results: EPS: ₹0.10 (down from ₹0.12 in 1H 2025). Revenue: ₹1.77b (up 15% from 1H 2025). Net income: ₹1.91m (down 15% from 1H 2025). Profit margin: 0.1% (in line with 1H 2025).New Risk • Nov 13New major risk - Revenue and earnings growthEarnings have declined by 7.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹344.7m market cap, or US$3.89m).공시 • Nov 07Cell Point (India) Limited to Report First Half, 2026 Results on Nov 12, 2025Cell Point (India) Limited announced that they will report first half, 2026 results on Nov 12, 2025공시 • Sep 03Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap - 530020, India분석 기사 • Aug 20Cell Point (India) (NSE:CELLPOINT) Has No Shortage Of DebtNSEI:CELLPOINT 1 Year Share Price vs Fair Value Explore Cell Point (India)'s Fair Values from the Community and select...New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Market cap is less than US$10m (₹331.7m market cap, or US$3.79m). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results.New Risk • Jun 25New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 502% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (₹347.6m market cap, or US$4.05m). Minor Risk Large one-off items impacting financial results.New Risk • May 21New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Market cap is less than US$10m (₹330.7m market cap, or US$3.86m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (0.07% net profit margin).분석 기사 • Jan 29These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt In A Risky WayLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...공시 • Sep 27Cell Point (India) Limited Declares Final Dividend for the Financial Year Ended March 31, 2024Cell Point (India) Limited announced at the AGM held on September 27, 2024, approved declare final dividend on equity shares at the rate of 2.5% [i.e. INR 0.25/- (Rupees Twenty Five paisa only) per Equity Share of Face Value of INR 10/- (Rupees Twenty Five paisa only) for the financial year ended March 31, 2024.공시 • Sep 13Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap-530009, IndiaNew Risk • May 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹644.7m market cap, or US$7.74m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹37.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 48x in the Specialty Retail industry in India.분석 기사 • Mar 13These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...New Risk • Nov 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹820.3m (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹820.3m market cap, or US$9.85m).New Risk • Nov 20New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 35% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (35% accrual ratio). Minor Risk Market cap is less than US$100m (₹833.4m market cap, or US$10.0m).공시 • Sep 08Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023, at 11:30 Indian Standard Time. Location: Door No 30-15-139/F/5, 6 Ward No 27, Ram's Arcade Opposite Visakha Medical Centre, Dabagardens Visakapatnam Andhra Pradesh IndiaValuation Update With 7 Day Price Move • Aug 03Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹55.55, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 38x in the Specialty Retail industry in India.Reported Earnings • Jul 22Full year 2023 earnings released: EPS: ₹4.93 (vs ₹1.21 in FY 2022)Full year 2023 results: EPS: ₹4.93 (up from ₹1.21 in FY 2022). Revenue: ₹2.96b (up 9.8% from FY 2022). Net income: ₹67.3m (up 309% from FY 2022). Profit margin: 2.3% (up from 0.6% in FY 2022). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to ₹49.05, the stock trades at a trailing P/E ratio of 55.7x. Average trailing P/E is 38x in the Specialty Retail industry in India.Board Change • Jun 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Ananda Ravada was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 CELLPOINT 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: CELLPOINT 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Cell Point (India) 배당 수익률 vs 시장CELLPOINT의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (CELLPOINT)0%시장 하위 25% (IN)0.3%시장 상위 25% (IN)1.5%업계 평균 (Specialty Retail)0.2%분석가 예측 (CELLPOINT) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 CELLPOINT 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 CELLPOINT 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: CELLPOINT Indian 시장에서 주목할만한 배당금을 지급하지 않습니다.주주 현금 배당현금 흐름 범위: CELLPOINT 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIN 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 09:27종가2026/05/22 00:00수익2025/09/30연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Cell Point (India) Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Sep 27Cell Point (India) Limited Declares Final Dividend for the Financial Year Ended March 31, 2024Cell Point (India) Limited announced at the AGM held on September 27, 2024, approved declare final dividend on equity shares at the rate of 2.5% [i.e. INR 0.25/- (Rupees Twenty Five paisa only) per Equity Share of Face Value of INR 10/- (Rupees Twenty Five paisa only) for the financial year ended March 31, 2024.
공시 • 23hCell Point (India) Limited to Report Second Half, 2026 Results on May 27, 2026Cell Point (India) Limited announced that they will report second half, 2026 results on May 27, 2026
Valuation Update With 7 Day Price Move • Apr 09Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹15.60, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 19x in the Specialty Retail industry in India. Total loss to shareholders of 13% over the past year.
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. Market cap is less than US$10m (₹254.1m market cap, or US$2.72m). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Large one-off items impacting financial results.
Reported Earnings • Nov 18First half 2026 earnings released: EPS: ₹0.10 (vs ₹0.12 in 1H 2025)First half 2026 results: EPS: ₹0.10 (down from ₹0.12 in 1H 2025). Revenue: ₹1.77b (up 15% from 1H 2025). Net income: ₹1.91m (down 15% from 1H 2025). Profit margin: 0.1% (in line with 1H 2025).
New Risk • Nov 13New major risk - Revenue and earnings growthEarnings have declined by 7.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 7.6% per year over the past 5 years. High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹344.7m market cap, or US$3.89m).
공시 • Nov 07Cell Point (India) Limited to Report First Half, 2026 Results on Nov 12, 2025Cell Point (India) Limited announced that they will report first half, 2026 results on Nov 12, 2025
공시 • Sep 03Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025Cell Point (India) Limited, Annual General Meeting, Sep 27, 2025, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap - 530020, India
분석 기사 • Aug 20Cell Point (India) (NSE:CELLPOINT) Has No Shortage Of DebtNSEI:CELLPOINT 1 Year Share Price vs Fair Value Explore Cell Point (India)'s Fair Values from the Community and select...
New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.8x net interest cover). Market cap is less than US$10m (₹331.7m market cap, or US$3.79m). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results.
New Risk • Jun 25New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 502% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Market cap is less than US$10m (₹347.6m market cap, or US$4.05m). Minor Risk Large one-off items impacting financial results.
New Risk • May 21New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Market cap is less than US$10m (₹330.7m market cap, or US$3.86m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (0.07% net profit margin).
분석 기사 • Jan 29These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt In A Risky WayLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
공시 • Sep 27Cell Point (India) Limited Declares Final Dividend for the Financial Year Ended March 31, 2024Cell Point (India) Limited announced at the AGM held on September 27, 2024, approved declare final dividend on equity shares at the rate of 2.5% [i.e. INR 0.25/- (Rupees Twenty Five paisa only) per Equity Share of Face Value of INR 10/- (Rupees Twenty Five paisa only) for the financial year ended March 31, 2024.
공시 • Sep 13Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024Cell Point (India) Limited, Annual General Meeting, Sep 27, 2024, at 11:30 Indian Standard Time. Location: 30-12-139, first floor, room no.5&6, ramas arcade, dabagardens, visakhapatnam, ap-530009, India
New Risk • May 31New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹644.7m market cap, or US$7.74m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end).
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹37.30, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 48x in the Specialty Retail industry in India.
분석 기사 • Mar 13These 4 Measures Indicate That Cell Point (India) (NSE:CELLPOINT) Is Using Debt ExtensivelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
New Risk • Nov 22New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹820.3m (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (₹820.3m market cap, or US$9.85m).
New Risk • Nov 20New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 35% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (35% accrual ratio). Minor Risk Market cap is less than US$100m (₹833.4m market cap, or US$10.0m).
공시 • Sep 08Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023Cell Point (India) Limited, Annual General Meeting, Sep 29, 2023, at 11:30 Indian Standard Time. Location: Door No 30-15-139/F/5, 6 Ward No 27, Ram's Arcade Opposite Visakha Medical Centre, Dabagardens Visakapatnam Andhra Pradesh India
Valuation Update With 7 Day Price Move • Aug 03Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹55.55, the stock trades at a trailing P/E ratio of 15.4x. Average trailing P/E is 38x in the Specialty Retail industry in India.
Reported Earnings • Jul 22Full year 2023 earnings released: EPS: ₹4.93 (vs ₹1.21 in FY 2022)Full year 2023 results: EPS: ₹4.93 (up from ₹1.21 in FY 2022). Revenue: ₹2.96b (up 9.8% from FY 2022). Net income: ₹67.3m (up 309% from FY 2022). Profit margin: 2.3% (up from 0.6% in FY 2022). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 32%After last week's 32% share price decline to ₹49.05, the stock trades at a trailing P/E ratio of 55.7x. Average trailing P/E is 38x in the Specialty Retail industry in India.
Board Change • Jun 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Non-Executive Independent Director Ananda Ravada was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.